Interestingly, a notable decrease in ALT levels by the Panax ginseng treatment was found in NAFLD-induced animals (SMD: −2.15 IU/L; 95% CI: −2.50 to −1.79 mg/dL; p < 0.0001) (Figure 3A). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.